NSAIDs and cardiovascular risk in arthritis

被引：0

作者：

Miguel A. González-Gay

Carlos González-Juanatey

机构：

[1] Miguel A. González-Gay is at the University of Cantabria,Rheumatology Division

[2] School of Medicine,Cardiology Division

[3] Instituto de Investigación Marqués de Valdecilla (IDIVAL),undefined

[4] Hospital Universitario Marqués de Valdecilla,undefined

[5] Avenida de Valdecilla,undefined

[6] s/n,undefined

[7] 39008,undefined

[8] Santander,undefined

[9] Spain.,undefined

[10] Carlos González-Juanatey is at the Hospital Universitario Lucus Augusti,undefined

[11] c/ Ulises Romero 1,undefined

[12] Lugo 27003,undefined

[13] Spain.,undefined

来源：

Nature Reviews Cardiology | 2017年 / 14卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

In the PRECISION trial involving patients with arthritis, moderate doses of a selective cyclooxygenase 2 inhibitor were not associated with increased cardiovascular events compared with submaximal doses of nonselective NSAIDs. The balance between pain relief and cardiovascular risk with NSAIDs should be further investigated in patients with chronic inflammatory rheumatic diseases.

引用

页码：69 / 70

页数：1

共 9 条

[1]

Castañeda S(2016)Cardiovascular disease in inflammatory rheumatic diseases Best Pract. Res. Clin. Rheumatol. 30 851-869

[2]

Nurmohamed MT(2016)Cardiovascular risk assessment in patients with rheumatoid arthritis: the relevance of clinical, genetic and serological markers Autoimmun. Rev. 15 1013-1030

[3]

González-Gay MA(2017)EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update Ann. Rheum. Dis. 76 17-28

[4]

López-Mejias R(2014)Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: scientific evidence and expert opinion Semin. Arthritis Rheum. 44 1-8

[5]

Agca R(2014)Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study Ann. Rheum. Dis. 73 1515-1521

[6]

Martín-Martínez MA(2009)Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients Ann. Rheum. Dis. 68 367-372

[7]

Lindhardsen J(2005)Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention N. Engl. J. Med. 352 1071-1080

[8]

Goodson NJ(undefined)undefined undefined undefined undefined-undefined

[9]

Solomon SD(undefined)undefined undefined undefined undefined-undefined

← 1 →